SEEL

Seelos Therapeutics, Inc. Common Stock
SEEL

Overview Fund Activity
Delisted

SEEL was delisted on the 15th of October, 2024.

Back to rankings

29 hedge funds and large institutions have $1.1M invested in Seelos Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 3 reducing their positions, and 4 closing their positions.

Holders
29
Holders Change
-1
Holders Change %
-3.33%
% of All Funds
0.65%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
3
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
1
Renaissance Technologies
New York
$36K
2
Citadel Advisors
2
Citadel Advisors
Florida
$24K
3
AAP
3
Ardsley Advisory Partners
Connecticut
$29K
4
Susquehanna International Group
4
Susquehanna International Group
Pennsylvania
$7K
5
UBS Group
5
UBS Group
Switzerland
$7K

Top Sellers

1
HVC
1
Healthcare Value Capital
New Jersey
$0
2
MML Investors Services
2
MML Investors Services
Massachusetts
$0
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$33K
4
FDCDDQ
4
Federation des caisses Desjardins du Quebec
Quebec, Canada
$134
5
VF
5
Virtu Financial
New York
$4K
Name Market Value Shares Shares
Change 		Shares
Change %
HI
26
Hudock Inc
Pennsylvania
$0 37 – –
Morgan Stanley
27
Morgan Stanley
New York
$0 200 – –
Royal Bank of Canada
28
Royal Bank of Canada
Ontario, Canada
$0 6 – –
BCM
29
Blume Capital Management
California
$0 3 – –
JPMorgan Chase & Co
30
JPMorgan Chase & Co
New York
$0 1,025 – –
Wells Fargo
31
Wells Fargo
California
$0 1,000 – –
CFGS
32
Concourse Financial Group Securities
Alabama
– – – –
AIC
33
Ameritas Investment Company
Nebraska
$0 26 +26 New
LFG
34
Larson Financial Group
Missouri
$0 80 +80 New
1
2